Redox implications in adipose tissue (dys)function-A new look at old
 acquaintances by Janković, Aleksandra et al.
Redox Biology 6 (2015) 19–32Contents lists available at ScienceDirectRedox Biologyhttp://d
2213-23
Abbre
binding
forkhea
peroxid
mutase;
nitric ox
prolifera
recepto
ROS, rea
Trx, thio
n Corr
E-mjournal homepage: www.elsevier.com/locate/redoxReview ArticleRedox implications in adipose tissue (dys)function—A new look at old
acquaintances
Aleksandra Jankovic a, Aleksandra Korac b, Biljana Buzadzic a, Vesna Otasevic a,
Ana Stancic a, Andreas Daiber c, Bato Korac a,n
a University of Belgrade, Department of Physiology, Institute for Biological Research “Sinisa Stankovic”, Bulevar Despota Stefana 142, 11060 Belgrade, Serbia
b University of Belgrade, Faculty of Biology, Center for Electron Microscopy, Belgrade, Serbia
c 2nd Medical Department, Molecular Cardiology, University Medical Center, Mainz, Germanya r t i c l e i n f o
Article history:
Received 15 May 2015
Received in revised form
25 June 2015
Accepted 30 June 2015
Available online 2 July 2015
Keywords:
Adipose tissue
Obesity
Insulin resistance
Redoxx.doi.org/10.1016/j.redox.2015.06.018
17/& 2015 Published by Elsevier B.V.
viations: AD, antioxidant defense; AGE, adva
protein; Cu, ZnSOD, copper zinc superoxide d
d-O-box; GAPDH, glyceraldehyde-3-phosphat
ase; H2O2, hydrogen peroxide; HIF, 1-hypoxia
mTOR, mammalian target of rapamycin; NAD
ide synthase; NOX, NADPH oxidase; NOX4, N
tor-activated receptor γ coactivator 1alpha; PK
r γ; Prx, peroxyredoxin; PTPs, protein tyrosine
ctive oxygen species; SIRT, sirtuin; SREBP1c, s
redoxin; TR, thioredoxin reductase; UCPs, un
esponding author. Fax: þ381 11 2761 433.
ail address: koracb@ibiss.bg.ac.rs (B. Korac).a b s t r a c t
Obesity is an energy balance disorder associated with dyslipidemia, insulin resistance and diabetes type
2, also summarized with the term metabolic syndrome or syndrome X. Increasing evidence points to
“adipocyte dysfunction”, rather than fat mass accretion per se, as the key pathophysiological factor for
metabolic complications in obesity. The dysfunctional fat tissue in obesity characterizes a failure to safely
store metabolic substrates into existing hypertrophied adipocytes and/or into new preadipocytes re-
cruited for differentiation. In this review we briefly summarize the potential of redox imbalance in fat
tissue as an instigator of adipocyte dysfunction in obesity. We reveal the challenge of the adipose redox
changes, insights in the regulation of healthy expansion of adipose tissue and its reduction, leading to
glucose and lipids overflow.
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Mostly due to the simplicity of the appearance of the adipose
tissue and adipocytes themselves, they are regarded as a long-
term storage of triacylglycerols (TAG) that is under dominant in-
sulin regulation. Adipose lipid reserves are deposited by lipogen-
esis in the state of nutrient abundance (high insulin level) and
hydrolyzed in the time of increased energy needs (low insulin
level) [1,2]. Up to now, the general belief was that normal adipose
tissue expands only passively to accommodate nutrient excess, as
well as that its excess per se (crudely measured as body mass in-
dex, BMI430, mass (kg)/height2 (m)) is enough for systemic in-
sulin resistance. In-depth investigation of adipose tissue was in-
stigated by the obesity pandemic in the last decades. It revealed
that prodigious morpho-functional plasticity and intricately con-
trolled flow of glucose and fatty acids through the adipocytes,
under different nutrient conditions orchestrate the nutrient flow
through the whole body, defining overall lipid and glucose
homeostasis [3–5]. As a matter of fact, regardless of the overallFig. 1. The structure of white adipocyte (A–C) and brown adipocyte (D–F) under light (A
two adipocytes types comprise of cell size, shape, and lipid droplets number. The most
white adipocytes go through “browning”, acquiring properties of brown adipocytes.BMI, the disruption of insulin-stimulated glucose uptake in adi-
pose tissue and insulin-mediated lipogenesis and adipogenesis,
which is most evident in visceral fat accumulation, appears to be a
sufficient trigger of peripheral insulin resistance [4].
There is increasing evidence for the concept of redox-driven
alterations of mitochondrial function as well as augmented mi-
tochondrial reactive oxygen species (ROS) formation as a key event
for the development of insulin resistance [6–8]. Moreover a hy-
pothesis emerged that excessive nutritional overload triggers re-
dox changes in adipocytes’ mitochondria, which impair local and
systemic insulin sensitivity [9–14].
The concept of redox signaling in adipocyte biology, and the
difficulties in understanding the roles of fat tissue in the main-
tenance of metabolic homeostasis, advanced in parallel a thorny
path. The offensive/defensive tendencies of oxidants/antioxidants
underwent in-depth reconsiderations after key observations that
were made over 40 years ago that oxidants can facilitate and mi-
mic insulin action [15], and that hydrogen peroxide (H2O2) is in-
tentionally generated by a specific enzyme in response to insulin, D) and transmission electron microscope (B, C, E, F). The differences between these
striking contrast is in mitochondrial population (C, F). Under some conditions, the
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it had been revealed that both oxidants and antioxidants de-
termine a highly dynamic, spatio-temporal redox metabolism in-
tricately involved in nutrient sensing and handling by the adipo-
cyte [17]. The focus of this review is to summarize the most im-
portant redox insights into adipocyte storage function, while
greatly emphasizing its changes in nutrient overload leading to
insulin resistance at the local and ultimately systemic level.2. Adipose organ: adipocyte cell types and depot-diversities
Anatomically, adipose tissue in the form of loose connective
tissue consisting of adipocytes and stromal-vascular cells is orga-
nized in distinct fat depots. Functionally quite heterogenous, fat
depots are integrated in a highly dynamic multidepot adipose
organ [18]. In regard to energy balance, this adipose organ may
appear as predominantly white – energy saving, brown – energy
dissipating, or beige (convertible) depending on the relative
amount of brown, beige/brite and white adipocyte types (Fig. 1).
These adipocytes, in respect to energy metabolism have a com-
pletely different function and can be differentiated by their char-
acteristic molecular signature [19]. Human adipose organ consists
mostly from white adipocytes, reflecting its primary, energy sto-
rage function. Discrete functional characteristics exist even be-
tween white adipocytes from different body sites. Compared to
subcutaneous adipocytes, adipocytes from the viscera are less in-
sulin sensitive, and the hypertrophic type of growth limits the
expanding capacity of the visceral adipose tissue depots [20–23].
Specified differences reflect the greater (theoretically limitless)
lipid storing capacity of subcutaneous adipose tissue, in contrast to
visceral adipose tissue that may function more as short-term lipid
storage. The stated depot-specifics also underlie the differences
between the healthy (insulin sensitive) and unhealthy (insulin
resistant) obesity in subjects with different adiposity distribution
(visceral vs. subcutaneous, respectively) in the long-term nutri-
tional (high calorie) overload.3. The role of adipose tissue in maintenance of systemic glu-
cose homeostasis
In the fluctuating nutritional states euglycemia level is tightly
upheld by a rate of glucose synthesis in the liver and by a rate of its
uptake in many tissues, but especially in liver, muscle and adipose
tissue [24]. Postprandial (or after a calorie rich meal) increase in
glucose level stimulates insulin secretion and the resulting hy-
perinsulinemia feedback increases synthesis of glycogen in the
liver and facilitates glucose uptake of insulin-sensitive tissues [24].
The significance of adipose tissue insulin signaling in the regula-
tion of overall glucose homeostasis was questioned by data
showing that fat-specific insulin receptor knockout (FIRKO) mice
are protected from obesity-related glucose intolerance and insulin
resistance [25]. On the other side, selective inactivation of the
glucose transporter 4 (GLUT4) gene in adipose tissue indeed in-
duced insulin intolerance and hyperinsulinemia, as well as im-
paired insulin action in muscle and liver [26]. In contrast to rat
adipose tissue that metabolizes 3–5% of glucose uptake [27], hu-
man adipose tissue is responsible for up to 20% of an orally ad-
ministered glucose load [28,29]. Thus, the role of insulin signaling
and action (glucose uptake and lipid sink) in adipose tissue is of
importance in systemic glucose homeostasis, during the feeding/
fasting state transitions [26,30,31], especially in obese humans
[32].
Chronic nutrient surplus and the resulting hyperinsulinemia
increase the adipocytes metabolic glucose flux and consequentlylead to an increase in cell size. As adipocytes are loaded with lipids
and reach the critical size, precursor cells may be stimulated to
differentiate, and an increase in adipocyte number occurs [33,34].
However, adipose tissue eventually becomes unable to store ex-
cess lipids, even with enhanced hyperplasia. This results in an
increased number of hypertrophic adipocytes. At one time-point,
hypertrophic adipocytes develop decreased sensitivity to insulin
and insulin mediated effects in adipose tissue: lipogenic and an-
tilipolytic control is impaired. Uncontrolled lipolysis results in free
fatty acids and glycerol release, further increasing plasma non-
esterified fatty acids level, their redistribution and interference
with the glucose uptake and metabolism in the liver and muscle
[20]. Impaired function of white adipose tissue (WAT) to buffer
excess metabolic substrates from nutritional overload, leaves the
non-adipose tissues, in particular liver and muscles to gluco- and
lipotoxic insults [35,36]. Overwhelmed glucose and fatty acid
buffering capacity of adipose tissue is especially visible post-
prandially, when the major nutrient overload occurs [37].4. Adipose tissue function (healthy expansion)
Postprandially, a high level of circulating insulin binds to its
receptors and mediates the regulation of the glucose and fatty
acids uptake in the adipose tissue, and the activity of enzymes
involved in their metabolism and deposition into TAG (lipogen-
esis). Over the longer term, lipogenesis results in adipose tissue
expansion (adipogenesis).
In general, binding of insulin to its receptors, induces receptor
autophosphorylation on tyrosine residues, accompanied by the
phosphorylation of insulin receptor substrates (IRS) by the activity
of insulin receptor tyrosine kinase. The IRSs are associated with
the regulatory subunit of phosphatidyl inositol 3-kinase, and after
multiple steps, this results in the translocation of GLUT4 contain-
ing vesicles toward plasma membrane and glucose uptake [38,39].
Glucose and TAG, ingested beyond the current energy demands,
are taken up by adipocytes (as glucose and fatty acids), converted
and stored in adipose tissue. Imported, as well as de novo syn-
thesized fatty acids from excess glucose, make up a common fatty
acids pool. Fatty acids aimed for storage combine with coenzyme
A, form thioester and then they are re-esterified in a stepwise
manner to form TAG. The TAG backbone – α-glycerol phosphate,
mostly comes from glucose in the fed state (glycolytic inter-
mediates) and lactate or pyruvate in the fasting state (glycer-
oneogenesis, i.e. shortened version of gluconeogenesis). De novo
fatty acid synthesis from glucose is high in insulin sensitive adi-
pocytes, especially after a high carbohydrate diet. Nicotinamide-
adenine dinucleotide phosphate (NADPH) needed for this re-
ductive biosynthesis is produced mostly by pentose-phosphate
pathway (PPP) (and by malic enzyme). Thus, the glucose uptake
and flux through the glycolytic pathway, PPP and glyceroneogen-
esis are of utmost importance for the lipogenic function of adi-
pocytes (all steps are summarized in [2,4]). Indeed, all metabolic
products of glucose increase in the fed state up to 10-fold, and they
increase along with adipocyte size. It is estimated that the con-
ventional products of the glucose metabolism, carbon dioxide and
TAG account for 40–50% of glucose metabolism in larger, insulin
sensitive cells vs. 80–85% of glucose metabolized in small, insulin
sensitive cells. Most of the glucose in the fed state in the insulin
sensitive, large adipocytes goes into lactate (50% and even 60–70%
in human adipocytes) [32]. Pyruvate conversion into lactate re-
oxidizes nicotinamide-adenine dinucleotide (NADH) into NADþ
needed for glycolitic pathway maintenance. Accumulated lactate
may be exported into the circulation and one part may also serve
as a precursor for de novo fatty acid synthesis. Thus, it has been
shown that increased glucose flux into lactate is paralleled by
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data, NADH/NADþ ratio has an essential role in the adipocyte
function, its healthy expansion after increased energy intake, but
also in its dysfunction to expand and to accommodate nutritional
overload [40,41].5. NADH/NADþ ratio is a new redox modulator of the adipose
tissue
In the fed state glucose is taken up by adipocytes, through in-
sulin-mediated glucose transport. Subsequently intensified flux
through the glycolysis and PPP supplies energy needed for adi-
pocyte activities and directs excess of metabolic substrates into
TAG synthesis (lipogenesis) [32]. The released electrons from PPP
are transferred to coenzyme NADPþ generating NADPH needed for
de novo lipogenesis, i.e. for the α-glycerol phosphate, fatty acids
and TAG synthesis [42]. In parallel, in the fed state, adipocytes shift
from oxidative to glycolytic ATP production. High glycolytic flux
generates NADH in cytosol originating from the oxidation of gly-
ceraldehyde 3-phosphate reaction, and NADþ must be re-
generated for glycolysis to continue. One part of NADþ is recycled
by lactate dehydrogenase with the raising lactate level. A moderate
shift in the NADH/NADþ ratio due to intensified glycolysis in the
fed state decreases the activities of all NADþ-dependent dehy-
drogenases downstream in regards to glucose oxidative degrada-
tion [40]. Moreover, the main sensor of the insulin-mediated
glucose flux through the cells, NADþ-dependent histone deace-
tylase (like Sirtuin 1 – SIRT1) are highly susceptible to decrease in
the NADþ/NADH level [43]. Depending on the nutrient availability
and NADþ/NADH ratio SIRT1 couples the cellular metabolic status
sensed via NADþ to the peroxisome proliferator-activated receptor
γ (PPARγ) expression and thus overall regulation of lipo- and
adipogenesis. Inactivation of SIRT1 by decreased NADþ/NADH ra-
tio, and subsequent inactivity of SIRT1-mediated signaling enables
transcriptional upregulation of lipogenesis and adipogenesis, by
relieving repression ofPPARγ [43].6. Reductive pressure, oxidative pressure and counterbalance
by mitochondrial antioxidant mechanisms
Enzymatic cofactors NADþ and flavine adenine dinucleotide
(FAD) “take over” and transfer the electrons from the oxidation of
metabolic substrates (glucose and fatty acids) to the complexes of
the mitochondrial electron transport chain (ETC) localized in the
inner mitochondrial membrane. As electrons are transferred along
the ETC to molecular oxygen, protons (Hþ) are pumped from the
mitochondrial matrix into the intermembrane space, establishing
a proton gradient across the inner mitochondrial membrane. The
energy of the proton gradient drives the synthesis of ATP by ATP
synthase and protons are transported back from the inter-
membrane space into the mitochondrial matrix [44].
In all aerobic cells most of the oxygen is reduced to water in the
mitochondrial ETC, but a significant part of oxygen molecules are
incompletely converted to H2O and end-up as superoxide anion
radical (O2), nonenzymatically, by the electron leak from the
complexes I and III [45,46]. The production of O2 is favored if the
ETC carriers are in a more reduced state achieved by (i) an in-
creased inflow of reducing equivalents (increased “push force” for
oxidative phosphorylation – OXPHOS) or by (ii) a decreased elec-
tron transfer capability of these carriers (decreased flow along the
ETC, and/or decreased “pull force” for OXPHOS) [47]. Thus, it has
been shown that in muscle high nutritional load increases the
NADH level (high “push force”) and augments the pressure on ETC
complexes, increasing the probability of electron leak, acceleratingO2 i.e. H2O2 production [47].
To prevent ROS excess, mitochondria are equipped with anti-
oxidant defense (AD) enzymes, like manganese superoxide dis-
mutase (MnSOD) that convert O2 into H2O2. This notably re-
active, non-radical molecule is further reduced to H2O in the mi-
tochondrial matrix by glutathione (GSH) peroxidase (GPx) and/or
thioredoxin/peroxyredoxin (Trx/Prx) systems. In contrast to the
tissues with high oxidative capacity, like muscle tissue, fat tissue is
characterized by a far lesser oxidative capacity and accordingly, a
lower level of AD components [48]. Similarly, there are differences
even between individual fat depots both in oxidative and anti-
oxidant capacity [49].
Apart from antioxidant systems, electron transfer capability of
the ETC regulated by uncoupling, plays an important role in the
setting of physiological ROS production by mitochondria during
the higher metabolite oxidation and NADH shift [50–52]. Mi-
tochondrial uncoupling decreases the pressure on ETC complexes,
increases their electron-transfer capability, thereby restraining the
leak of electrons and subsequent production of O2 . Con-
currently, the leak of Hþ uncouples the electron transport and ATP
synthesis wasting the proton gradient (energy of metabolic sub-
strates) as heat. It may be spontaneous, or mediated by mi-
tochondrial uncoupling proteins (UCPs) [53]. Both, antioxidant and
energy dissipating effects of UCPs are mutually connected. This
refers even to thermogenin or uncoupling protein 1 (UCP1) in
brown adipocytes, essential effectors of thermoregulatory diet-
and cold-induced non-shivering thermogenesis [54–56]. The pro-
ton leak catalyzed by UCP1 is fatty acid dependent, and two pro-
posed mechanism of fatty acid dependent-UCP1 function seem to
operate in vivo. According to the first mechanism, fatty acids act as
cofactors/activators [57], while the second “flip-flop” mechanism,
proposes that protonated fatty acids freely cross the mitochondrial
inner membrane into the matrix, and upon deprotonation, the
resulting fatty acid anions are “flipped back” across the inner
membrane by UCP1 [58,59]. Thus, UCP1 activity increase is closely
associated with increased mitochondrial flux (cycling) of fatty
acids.
The UCP1 in non-brown/beige adipocytes or non-adipose tissue
(e.g. thymus) seems to have a more general physiological role,
beyond energy wasting [60]. Transient increase of UCP1 expres-
sion in rat white adipocytes observed under cold exposure may be
rather associated with increased lipolysis and fatty acid flux [61].
Actually, different roles of UCP1 in white (with low oxidative ca-
pacity) vs. beige/brown adipocytes (highly specialized to oxidize
fatty acids) within whole adipose organ seems to be analogous to
the different roles that UCP3 has in glycolytic type 2b and oxida-
tive type 1 muscle fibers within muscle, respectively [62]. Thus, it
may be speculated that transient upregulation of UCP1 in white
adipocytes, like UCP3 in glycolytic muscle fibers, occurs as a de-
fense, when fuel delivery and/or intensified flux of fatty acids
exceed the oxidation capacity of adipocytes. The physiological
meaning of UCP1 increase in white adipocytes is still vague, but
seems to intricately link the oxidative metabolism, reductive
pressure, i.e. consequent oxidative pressure in these cells.
In support, Carriere et al. [63] show that an increase in NADH
production in mouse and human white adipocytes induces their
“browning”, with the morphological characteristics of brown adi-
pocytes. At the metabolic level there is a clear switch towards an
oxidative, mitochondrial phenotype. This is followed by a strong
expression of functionally active UCP1 in these brown-like adi-
pocytes [63]. The authors elegantly show that L-lactate (and also β-
hydroxybutyrate) induces white adipocyte remodeling, directly
affecting the intracellular redox state by increasing NADH pro-
duction in the cytoplasm or mitochondria. L-Lactate, either pro-
duced or taken up by white adipocytes via monocarboxylate
transporters, can be oxidized to pyruvate in cytoplasm by lactate
A. Jankovic et al. / Redox Biology 6 (2015) 19–32 23dehydrogenase. Also, L-lactate can enter mitochondria (most
probably via symport with protons), and further be oxidized in the
matrix by mitochondrial lactate dehydrogenase, whose existence
has been documented in different cell types [64]. Increased NADH
in the matrix elevates mitochondrial oxidative phosphorylation
and the entire oxidative metabolism (pyruvate or lactate oxida-
tion), which as a result has the higher oxidative pressure in white
adipocyte mitochondria. The authors point out that the increase of
UCP1 expression is in fact an adaptive response to L-lactate–
NADH-induced redox pressure in white adipocytes. In other
words, the redox-dependent UCP1 induction in white adipocytes
does not have a thermoregulatory uncoupling function, as in
brown adipose tissue, but better suits the so called “mild” un-
coupling postulated by Skulachev [50], as a special mechanism in
mitochondria which prevents a strong increase of electrochemical
potential and consequent increment of ROS production. The ob-
servation that a lower level of UCP1 usually characterizes obese
subjects, in comparison to normal-weight subjects [65], has raised
the hypothesis that increasing UCP1 in human adipose tissue in
physiological frameworks may be a promising anti-obesity target.
However, if the main role of UCP1 induction in WAT (browning) is
to alleviate the oxidative pressure because of incoming nutrient
(reducing equivalent) excess on the ETC, it would be increased, but
only in the extent of limiting the ROS burst. Thus, increasing white
adipocyte browning by different agents may in turn cause insulin-
sensitization opposed to presenting us with an anti-obesity tool.
Furthermore these effects are not mutually exclusive, nor do they
preclude the thermogenic role of UCP1, and they may in fact be a
part of the same phenomenon.7. Nutritional signaling in adipose tissue: mitochondria,
NADH, and H2O2
Emerging lines of evidence indicate that both genuine AD and
antioxidant effect of uncoupling in tissues, including the adipose
tissue, are important as nutrient sensors (the sensors of reducing
equivalents) in mitochondria and the active effectors mediating
ROS-dependent signaling from mitochondria [66].
Initially, O2 and H2O2, generated at the mitochondrial re-
spiratory complexes, were regarded as inevitable injurious by-
products, and it was thought that their passive accumulation leads
to different degenerative diseases and aging [67–69]. Thus, the
superoxide dismutases (SODs), MnSOD and Cu, ZnSOD, as well as
H2O2-metabolizing enzymes and antioxidant molecules have been
considered only as essential cellular protectant molecules. How-
ever, discovery of the enzymes that intentionally produce ROS, like
the NAD(P)H oxidases suggested that fluxes of O2 and H2O2, in
the low, physiological range, play important signaling functions
[70–72]. In this context, antioxidant enzymes now appear to be
major players in both antioxidant defense and redox signaling.
As a mild oxidant, passing throughout the various cell com-
partments, H2O2 may act directly, specifically and reversibly with
the redox-sensitive sulfhydryl groups in key cysteine residues of
various signaling proteins/their binding partners, especially pro-
tein phosphatases, different metabolic enzymes and transcription
factors [73]. Likewise, H2O2 may shift the ratio of reduced glu-
tathione to oxidized glutathione, the main redox buffer in the cell,
and thereby also promote redox-regulation of enzymatic activity
by S-glutathionylation. Also important enzymes of the energy
metabolism (e.g. glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) and isocitrate dehydrogenase) may be redox-controlled
by this mechanism [67,74,75]. Reversible oxidation of the cysteine
sulfhydryl group acts as an “on-off” switch for changing structural
configuration of proteins and thereby affecting their activity, lo-
calization and half-life [76,77]. Recently, it has been revealed thatmitochondrial O2 , i.e. H2O2 emission in different cells serves as
both, an estimate of energy balance and as a determining factor of
cellular redox environment, thus linking cellular metabolic bal-
ance to the control of their insulin sensitivity [51,78]. Thus, low,
intermittent emission of H2O2 from mitochondria, following nu-
trient load, seems to be essential in the transient shifts in the in-
tracellular redox environment to a more oxidized state [51]. This
transient peroxidative shift may lead to oxidations and thus reg-
ulation of activity of numerous enzymes (mainly by oxidizing their
Cys residues in catalytic or regulatory sites) in the cytosol, in-
cluding the highly susceptible protein tyrosine phosphatases
(PTPs), involved in insulin signaling [79]. Their transient in-
activation thereby may relieve many kinases from the insulin
signaling to promote transduction of the insulin action in the
adipocyte. Once the level of H2O2 has returned to basal level, the
alteration is reversed, and the activity of the protein reverts to its
initial level, in the case of PTPs, their activation, and thus insulin
signaling cessation [80]. Likewise, activation of the renin–angio-
tensin–aldosterone-system (RAAS) was reported for hypergly-
cemic and obese patients [81,82] leading to increased peroxyni-
trite formation associated with nitration/inactivation of Akt, ni-
tration/activation of MAP kinases ERK1/2 and impaired insulin
signaling [83].
In the context of normal nutrient supply, thereby transient rises
in metabolic fluxes, and subsequent intermittent increase of ROS
(O2 , and H2O2) from the mitochondria has been recognized in
various tissues, primarily muscles [51], brain [84], hypothalamus
[85,86] and pancreatic β-cells [32], and recently also in the adipose
tissue during the adipogenesis [87]. In adipose tissue, mitochon-
drial ROS production under increased glucose (or glucose meta-
bolites) fluxes has mostly been studied in hyperglycemic diabetics
[88,89], but it can be hypothesized that the similar redox changes,
although less evident, may be seen in the prediabetic states, no-
tably after continuous overconsumption of high carbohydrate,
high fat diet.8. Adipose tissue (dys)function
8.1. H2O2 output by NADPH oxidase
Oxidative stress, commonly defined as the consequence of an
imbalance between pro-oxidant processes and antioxidant me-
chanisms leading to a deviation from the steady-state [90], play an
instigating (preceding) role in the development of local and per-
ipheral insulin resistance – and not only represent the con-
sequence of the existing hyperglycemia [91]. From the recognition
that insulin itself elicits the generation of H2O2 in adipocytes [92],
and that excess of H2O2 may inhibit insulin signaling pathway [93],
the insulin-instigated H2O2 production and redox signaling were
in the center of the adipocytes insulin sensitivity regulation
[79,80,94] and dysfunction [91].
NADPH oxidase (NOX) proteins are membrane-associated
multimeric enzymes, that transport electrons preferentially from
cytosolic NADPH (although nonphagocytic NADPH oxidases may
also use NADH as substrate) down an electrochemical gradient
through FAD, NOX heme groups, and finally through the mem-
brane to oxygen, generating O2 , which is rapidly converted to
H2O2 [95,96]. Among the (currently seven) NOX isoforms, phago-
cytic NOX2 (in the macrophages) and NOX4 (in the adipocytes) are
highly expressed in adipose tissues [97]. NOX4 can act as a switch
between differentiation and proliferation in preadipocytes [98].
Unlike other NOX proteins, NOX4 can directly generate H2O2 even
under basal conditions, in the absence of exogenous stimuli
[96,99]. However, insulin, as well as some other (anabolic) hor-
mones and cytokines induce a multi-fold increase in
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expression of NOX4 [80]. In fact, it is noted that H2O2 production
by NOX may be activated by various cellular stressors, including
ROS itself [100,101].
NOX4 upregulation by insulin is well known, but the under-
lying mechanisms are not solved finally. It is clear however, that
besides the gene expression level, NOX4 activity may be regulated
by protein modification [94]. Most importantly, as stated above,
NOX4 enzyme activity is redox-regulated by its own product, H2O2
[94,102]. It is hypothesized that a self-limiting (feedback) me-
chanism may be involved in the low, physiological H2O2 output of
non-phagocytic NOX. Li et al. showed also a feed-forward me-
chanism of NOX regulation by its product [103]. Precisely, it has
been shown that exogenous exposure of fibroblasts to H2O2 acti-
vates NOX to produce endogenous O2 , thereby amplifying ROS-
mediated injury. This is important since it reveals that redox-de-
pendent regulation of NOX activity in adipocytes is functionally
important in transducing extracellular oxidative stress signals
in vivo, through interaction with neighboring cells, such as
macrophages.Fig. 2. Crosstalk between different sources of reactive oxygen and nitrogen species
(mitochondria, NADPH oxidases, xanthine oxidase (XO) and nitric oxide (NO)
synthase). Hyperglycemia and obesity lead to activation of primary ROS sources
such as mitochondria (mtROS, due to metabolic dysregulation) and NADPH oxi-
dases (Nox-derived ROS, due to low-grade inflammation). Signaling by advanced
glycation end products (AGE) and their receptor (RAGE) might also trigger the
activation of NADPH oxidases. These primary ROS sources can activate each other in
a crosstalk fashion via so-called “kindling radicals” with the potential involvement
of redox-sensitive mitochondrial pores (mPTP, mitochondrial permeability transi-
tion pore and mKATP, mitochondrial ATP-sensitive potassium channel) and protein
kinases (PKC). Primary ROS from mitochondria and Nox enzymes can also activate
secondary ROS sources such as xanthine oxidase (by oxidative conversion from the
dehydrogenase form) and uncoupled nitric oxide synthases (by uncoupling via
several redox switches). The ROS-induced ROS formation can initiate vicious circles
that further aggravate the disease progression and stimulate AGE/RAGE signaling as
well as low-grade inflammation.
Modified from Biochim Biophys Acta 1797 (2010) 897–906. With permission by
Elsevier.9. NOX-driven redox communication between adipocytes and
macrophages
Obesity is accompanied by a phenotypic transformation of
adipose tissue macrophages (ATMs), from an anti-inflammatory
“alternatively activated” M2 form, to a more proinflammatory
“classically activated” M1 form that express different proin-
flammatory factors, which include tumor necrosis factor α (TNF-α)
and inducible nitric oxide synthase iNOS [104,105]. The pro-in-
flammatory state of adipose tissue imposed by phenotypic trans-
formation of ATMs may be a potential mechanism, whereby obe-
sity leads to insulin resistance [105]. Primarily, a paracrine loop
involving saturated fatty acids and TNF-α derived from adipocytes
and macrophages, respectively, aggravates obesity-induced adi-
pose tissue inflammation and dysfunction, i.e. systemic insulin
resistance [106]. A growing body of evidence indicates that adi-
pocytes and macrophages (and possibly other cells in the stromo-
vascular fraction of adipose tissue) communicate and affect each
other function/phenotype and overall (dys)function of adipose
tissue – through redox mechanisms.
Increased oxidative pressure can lead to immune cell activation
[101,107] or vice versa inflammatory cells upon infiltration to
tissues can lead to cellular oxidative damage, as was recently de-
monstrated in the angiotensin II infusion model [108]. In order to
introduce the vicious circle initiated by immune cells in adipose
tissue, a pro-inflammatory state in obesity and hyperglycemia was
reported [109], leading to activation of the potent ROS source
NOX2 in infiltrating phagocytic cells. Most importantly, reducing
the mitochondrial hydrogen peroxide levels by overexpression of
catalase in mitochondria resulted in impaired bacterial killing
[110]. Finally, increased superoxide/hydrogen peroxide formation
was associated with the activation of the NLRP3 inflammasome,
innate immune defenses and subsequent production of pro-in-
flammatory cytokines [111].
Still, macrophages are recognized to play an important role in
adipose tissue healthy remodeling during both, expansion and
regression of adipose tissue (e.g. in obesity or after 24 h fasting,
respectively) [5]. In fact, increased flux of fatty acids in adipose
tissue requires ATMs to create a permissive environment for the
remodeling process i.e. homeostatic expansion/regression of adi-
pose tissue [5]. However, a sustained interaction between en-
dogenous ligands (fatty acids) derived from adipocytes and pa-
thogen sensors expressed in macrophages leads to chronic in-
flammatory responses ranging from the basal homeostatic state todiseased, dysfunctional adipose tissue remodeling, which may be
referred to as “homeostatic inflammation” [112]. In parallel with
this, it can be hypothesized that a sustained feed-forward reg-
ulation of NOXs in adipocytes by NOXs frommacrophages and vice
versa, has a significant role in the adipose tissue redox state, and
remodeling, ranging from homeostatic to dysfunctional. Finally,
considering the role of NOX4 in the propagation of insulin signal in
adipocytes, insulin sensitivity of adipocytes may be regulated
through the complex intercellular NOXs, i.e. H2O2 mediated cross-
communication.10. NOX-mitochondrial cross-talk
Emerging evidence suggests important NOX4 cross-talk with
the mitochondria [113], activation of NOX1/2 by mitochondrial
ROS [107,114] and vice versa of mitochondrial ROS by NOX2
[115,116]. In particular, mild mitochondrial dysfunction and mi-
tochondrial ROS formation might abolish the responsiveness of
NOX, although the baseline H2O2 production by NOX is in fact
enhanced [117]. Dysfunctional mitochondria can also activate ROS
formation in neighboring mitochondria in a redox-dependent
fashion [118,119]. In general, any biological source of ROS may be
activated in a crosstalk fashion by ROS derived from other sources
(e.g. NOX-derived ROS may uncouple nitric oxide (NO) synthases
(NOSs) and trigger NOS-derived ROS formation or xanthine oxi-
dase is activated by ROS-dependent cysteine oxidation) as shown
in Fig. 2 [101]. As a consequence, all classical sources of ROS were
found to be activated under hyperglycemic conditions [120].
Overall, the studies on different cells consistently indicate that
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stream of mitochondria [114,121]. This cross-talk may be of utmost
significance in defining redox insights into adipose tissue function
and insulin insensitivity development (dysfunction).
Another major concept of diabetic pathology (also applying to
the metabolic syndrome as observed in obesity) is based on direct
glucotoxicity, including increased formation of advanced glycation
end products (AGE) and their signaling via specific receptors
(RAGE) leading to vascular dysfunction and end organ damage
[122,123]. Most importantly, oxidative stress and AGE/RAGE
components interact with each other in a cross-talk fashion,
wherein AGE/RAGE signaling can activate sources of ROS [124,125]
and normalization of mitochondrial ROS formation in turn nor-
malizes hyperglycemic damage by decreasing AGE/RAGE signaling
[126] (Fig. 2). In 2001, it was demonstrated that macrophages from
gp91phox deficient mice responded less to AGE stimulation pro-
viding a direct link between AGE/RAGE signaling and NADPH
oxidase expression/activity [125]. The same authors also demon-
strated a connection between AGE/RAGE signaling and in-
flammation by increased vascular cell adhesion molecule-1
(VCAM-1) and tissue factor expression in human endothelial cells
in response to AGE treatment.11. Instigating role of mitochondrial ROS in insulin resistant
adipocyte response
Mitochondrial dysfunction and oxidative stress have been
consistently recognized to be implicated in the etiology of insulin
resistance [10,12]. However, the evidence supporting a specific
role for mitochondrial O2 in adipocytes insulin resistance was
limited in comparison to well recognized responsibility of
NOX4–H2O2-producing system [91]. The (patho)physiological role
of mitochondrial ROS in insulin sensitivity was mostly recognized
in muscles, the tissue with high oxidative capacity, while in adi-
pocytes, as mostly oxidative dormant cells, this source of ROS, as
well as the mitochondria as a whole were mostly underestimated.
The first evidences that mitochondrial ROS play an important role
in adipocyte insulin resistance were provided by Houstis et al. [10],
after the recognition of an increase in adipocyte mitochondria
during the differentiation of adipocytes [127]. It was recently ac-
centuated that increased mitochondrial phosphorylation due to
increased influx of nutrients in the absence of ATP consumption
increases ADP availability and increases the occupancy of the
electron carriers, increasing the probability of an electron leak and
O2 generation [12]. Namely, by using the mitochondria-targeted
dye, highly specific for O2 , Hoehn et al. [12] have shown that
increased mitochondrial O2 production actually lies upstream of
insulin resistance. Using a minimal but chronic exposure to in-
sulin, corticosteroids, cytokines and lipids did not show consistent
change in the proximal part of the insulin signaling (PI3K/Akt)
pathway [128], indicating indeed that there is a direct causal link
and instigating role of the mitochondrial ROS, with insulin re-
sistant response of adipocytes. These data were confirmed by the
results showing that both, uncoupling agents and MnSOD mi-
metics, that alleviate O2 in the ETC rapidly restore insulin sen-
sitivity of adipocytes [12]. Finally, although the insulin resistance
and diabetes type 2 are associated with mitochondrial dysfunc-
tion, hyperinsulinemia is in fact, associated with an increase in
mitochondrial oxidative phosphorylation [129]. These results
support the assumption that mitochondrial oxidative pressure in
nutrient oversupply (especially high calorie intake) is the pre-
ceding factor that – if not compensated with UCPs or mitochon-
drial-targeted antioxidants, over time, may lead to mitochondrial
dysfunction – evident in insulin resistance (Fig. 3). Intriguingly,
insulin resistant response of adipocytes is not viewed asdysfunction, but as an appropriate, functional response of adipo-
cytes to defend themselves from nutrient excess. In fact, by sup-
pressing glucose uptake, adipocytes decrease the metabolic pres-
sure (inflow of electrons to ETC from high NADH), and conse-
quently ROS release. In such context insulin resistant response of
adipocytes becomes the last-line antioxidant defense response.
According to Frizzel et al. [89] when elevated carbohydrate fuel
supply exceeds the metabolic needs of the cell, there is an over-
production of reducing equivalents, namely NADH. ATP accumu-
lation in adipocytes may lead to feedback inhibition of OXPHOS
and ATP synthase and induce a high membrane potential. Ac-
cordingly, electron flow is inhibited and the NADH concentration
rises. This increase of the NADH/NADþ ratio, in diabetes type 2 is
well described as “reductive stress”, i.e. pseudohypoxia in the ab-
sence of actual hypoxia [130]. A dramatic increase in NADH may
cause (i) feedback inhibition of all NADþ-dependent dehy-
drogenases in the tricarboxylic acid (TCA) cycle and the accumu-
lation of TCA intermediates, like the fumarate and malate, further
leading to succination of Cys in wide range of proteins [89].
Moreover, raised NADH levels may exceed the acceptor capacity of
its main electron acceptor in the ETC – complex I, perpetuating an
electron leak, and O2 i.e. H2O2 generation. Both, a leak of elec-
trons from ETC, as well as the increased fumarate lead to irrever-
sible modifications of prolyl-4-hydroxylase, enzyme that catalyzes
hydroxylation of the Pro residues in the hypoxia-inducible factor
1 alpha (HIF-1α), and thus permanently stabilizes HIF-1α, leading
to the state of “pseudohypoxia” [131].
Excessive increase of ROS, i.e. by mitochondria, may have pro-
found effects on multiple levels, including different tissue com-
partments, from the mitochondrial ETC and the mitochondria it-
self (TCA cycle enzymes etc.) through the upstream metabolic and
regulatory enzymes, like GAPDH. Important enzymes of the energy
metabolism (e.g. GAPDH and isocitrate dehydrogenase) may be
redox-controlled by oxidation/reduction of cysteine residues
[67,74,75]. Thereby, accumulation of intermediate of glycolysis
stimulate the other related pathways (polyol, hexosamine, the
protein kinase C – PKC activation, advanced glycation end pro-
ducts, and glyceraldehyde autooxidation) [68], further dis-
seminating ROS, particularly O2 , and consequently, H2O2.
The moderate, transient (oscillatory) mitochondrial ROS may
induce opening of mitochondrial permeability transition pore
(mPTP) and associated ROS release from mitochondria has been
regarded as an adaptive housekeeping function by the timely re-
lease from mitochondria of accumulated potentially damaging
levels of ROS [119]. However, higher ROS levels and longer mPTP
openings may release a ROS burst (ROS-induced ROS release)
leading to destruction of mitochondria, and if propagated from
mitochondrion to mitochondrion, of the cell itself.
ROS released out of mitochondria may activate local pools of
redox-sensitive enzymes [119]. ROS, primarily H2O2, may ascend
even the proximal parts of the insulin signaling pathway and
NOX4 itself. Even more, H2O2 may diffuse out of the adipocyte
affecting neighboring adipocytes, preadipocytes, endothelial cells
and tissue macrophages. H2O2 may pass membranes of different
cellular compartments also by diffusion that is facilitated by
aquaporins, in a more regulated manner [132] and depending on
the H2O2 concentration as well as the membrane phospholipid
composition, differently affecting cellular compartments.
Thus, H2O2 metabolism and transduction inside and out of
adipocytes may be regarded as an auto/paracrine signal integrat-
ing the nutrient sensing of adipose tissue with its metabolic and
structural remodelling enabling functional fat expansion. Its im-
pairment however, may lead to adipose tissue dysfunction.
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Besides mitochondria, different oxido-reductase systems, like
nitric oxide (NO) synthases (NOS) and NOX, can transfer electrons
to O2 in NAD(P)H-dependent reactions [133,134]. These enzymes
can serve as an important source of superoxide in adipose tissue.
In this regard, NOSs, apart from NOX, are of particular importance.
NOS catalyzes the formation of NO from L-arginine via two
successive steps involving an electron transfer between the
C-terminal flavin-containing reductase domain and N-terminal
heme-containing oxygenase domain [135]. Under certain condi-
tions, the enzymatic activity of NOS can be uncoupled to produce
O2 rather than NO, e.g. when the concentration of NOS cofactor
tetrahydrobiopterin or substrate L-arginine is too low as well as
several other redox-controlled pathways (e.g. accumulation of
asymmetric dimethylarginine, adverse phosphorylation by PKC or
protein tyrosine kinase-2, oxidative disruption of the zinc–sulfur-
complex at the dimer binding interface) [101,109]. The oxidized
form of tetrahydrobiopterin is unable to donate an electron to
synthesize NO, while peroxynitrite is formed from concomitant
generation of superoxide and NO by uncoupled NOS [136]. The NO
has important roles in the adipocytes metabolism and particularly
mitochondrial bioenergetics, in both brown [137,138] and white
adipocytes [139,140]. There are also direct in vivo evidences that
insulin stimulation of glucose uptake [141] and the induction of
UCP1 (unpublished data), antioxidant defense [142] and oxidative
capacity [143] in WAT are all stimulated by L-arginine, i.e. NO.
Moreover, the effects of NO depend on the rate of its synthesis by
NOSs and its availability that may be determined by the current
O2 level. There is clear evidence that adipocytes contain nitric
oxide synthase, most likely endothelial NOS [144–146]. Un-
fortunately, the role of NO in WAT remains out of the scope of the
current review but the close interaction of inflammation in fat
tissue, adipocyte (dys)function and regulation of the vascular tone
is currently a major field of interest [147].13. Redox insights into adipogenesis
Some transcription factors may be activated, leading to en-
hanced target gene expressions in the presence of oxidants. Be-
sides well-known redox-dependent transcription factors involvedFig. 3. Hypothetical model of insulin resistance development in response to nutrition o
which is thereby stored in form of triacylglycerols. Storage of lipids requires marked up
glycolysis and OXPHOS), intermediates for fatty acid and glycerol synthesis (via glycoly
glycolysis, TCA cycle and PPP). An increased level of serum insulin after a meal stimulat
anti-lipolytic effect. Glucose uptake further leads to draining of electron-driven energy fro
cell. Enhanced ‘push force’ (NADH and FADH2) for the OXPHOS speeds up flux through
from the complexes I and III of OXPHOS onto O2, generates O2 , which is promptly con
in a controlled manner, may oxidize and thus regulate the activities of numerous enzyme
H2O2 has long been known as an insulin-mimicking molecule, which amplifies insuli
production, H2O2 is also generated in a strictly-controlled, intentional way by NOX4. T
optimal range of H2O2 within the cell. Also, there are some other mechanisms that pr
electrochemical gradient on the two sides of the inner mitochondrial membrane. Howe
markedly up-regulated, leading to a significant increase in reductive pressure, and con
protects itself from oxidative injures by increasing antioxidant mechanisms: antioxidan
balance). Up to here, no or few pathological events occur, and thus it is still legitimate to
when this up-regulated metabolism will cause slipping into pathology. (C) Namely, persi
moment, exceed the antioxidant capacity of the cell. If this happen, oxidative injures beg
and subsequently, signaling pathways (insulin resistance), organelles (mitochondria) and
the anti-lipolytic effect of insulin, leading to hydrolysis of triacylglycerols and enhanced
and may induce insulin resistance on the systemic level. As for the arbitrary correlation b
be seen as function, not dysfunction, of adipocytes, because in this way the cells protec
generation (the last line of defense in the cell).in the upregulation of AD enzymes (nuclear factor-erythroid
2-related factor 2, nuclear factor-kappa B, activator protein-1, and
tumor protein p53), the crucial adipogenic factors – PPARγ and
CCAAT/enchancer binding proteins (C/EBPs) are redox sensitive
[148]. According to the raising data impaired redox regulation
interferes with the adipogenic capacity of adipose tissue through
the regulation of pro- and anti-adipogenic factors.
As a response to nutritional overloads and the need for addi-
tional fat stores, adipose tissue can expand by means of pro-
liferation and differentiation [149]. Obesity in the adult human is
mainly hypertrophic, caused by hypertrophy of adipocytes with
increased lipid accumulation. De novo adipocyte formation from
stem cells might be responsible for continuous turnover of fat cells
in the body [150]. Remarkably, evidence has indicated that the
recruitment of new preadipocytes, in subcutaneous adipose tissue,
capable of undergoing adipogenic differentiation to mature adi-
pocytes is actually reduced. Based on this, it is estimated that re-
storing the impaired preadipocyte differentiation in subcutaneous
adipose tissue may be a new approach to increase its expanding
capacity, prevent the lipid overfill to visceral and nonadipose tis-
sues and resultant insulin resistance [150,151]. It is likely that ROS
may produce contrasting effects on adipogenesis depending on the
adipogenesis state and intensity of ROS generation [152].
Adipogenesis is a complex two-step process involving a highly
orchestrated program of transcriptional regulation of pro- and
anti-adipogenic factors, mitochondriogenesis and mitochondrial
remodelling paralleled by increasing insulin signalling, triglycer-
ides accumulation and the redox changes [127,152,153]. Adipo-
genic process occurs via the commitment of mesenchymal stem
cells toward preadipocyte fate, and terminal differentiation of
preadipocytes into mature adipocytes [152]. A number of different
pro- and anti-adipogenic transcription factors control the adipo-
genic program, and the PPARγ and C/EBPα are considered to be
master regulators of the adipogenic process [4,152]. These factors
are upregulated by transient upregulation of C/EBPβ and C/EBPδ.
Besides, sterol-regulatory element binding protein 1c (SREBP1c)
itself regulated by insulin and lipids activates PPARγ and directly
upregulates lipogenic enzymes (fatty acid synthase, lipoprotein
lipase). Together, these factors contribute to lipogenesis and the
final differentiation of adipocytes [154–156].
ROS are involved in both steps of adipogenesis. Increased O2
and H2O2 production occur in the early and terminal adipocyteverload. (A) Postprandially, adipocytes serve as sink for excess fatty acids, most of
take, conversion and oxidation of glucose molecules to build up the ATP pool (via
sis and TCA cycle), as well as reducing equivalents for biosynthetic processes (via
es glucose uptake by adipocytes via GLUT4, while simultaneously showing a great
m the fuel, and subsequently, results in an increase of reductive pressure within the
the respiratory chain, and thus, increases ROS production. Leakage of the electrons
verted to H2O2. This freely diffusible and notably reactive molecule, when produced
s (mainly by oxidizing their Cys residues in catalytic or regulatory sites). Due to this,
n-triggered signaling through the cell. Besides this casually-based mitochondrial
hese pathways of H2O2-productions are mutually interrelated, thus providing an
event excessive production of ROS, such as AD and uncoupling that decreases the
ver, in the case of nutritional overload (B), all of the above-described pathways are
sequently, an increase in oxidative pressure as well. In these conditions, the cell
ts, antioxidant enzymes, uncoupling etc. (newly established oxidative-antioxidant
talk about cell function. However, this is ‘walking on a string’ and it is a question of
stent nutritional overload, and consequent oxidative pressure, may easily and at any
in to accumulate leading to irreversible damage of proteins and other biomolecules,
the cell in whole. Blockage of the insulin-signaling pathway in adipocytes removes
outflow of fatty acids from WAT, which now have to deposit in the liver and muscle,
etween function and dysfunction, it is important to note that insulin resistance may
t themselves from excessive uptake and metabolism of glucose, which drives ROS
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mitochondrial function and the NOX4 [98,157]. Carriere et al. [158]
demonstrated that an increase in mitochondrial ROS production
caused by inhibition of the ETC impedes preadipocyte proliferation,
while it was also observed that in the early phase of adipocyte dif-
ferentiation of human mesenchymal stem cells, there was an in-
crease in mitochondrial metabolism and ROS generation. Moreover,
the authors demonstrated that ROS production from mitochondrial
complex III was required for activation of the adipogenic transcrip-
tional cascade via upregulation of C/EBPα and PPARγ [157].
In fact, various oxidant compounds, including the inhibition of
glutathione synthesis, increase transcriptional activity of PPARγ
[159,160]. Recently, Schopfer et al. have recognized redox-sensitive
Cys285, located in the ligand-binding domain of PPARγ [161]. Also,
it was shown that oxidative conditions induce disulfide bond
formation between Cys296 and Cys143 and dimerization of C/
EBPβ, additionally potentiating its phosphorylation-, oxidation-,
and dimerization-dependent DNA binding activity [162]. Among
different oxidants, H2O2 seems to be an important ROS signaling
molecule in the transcriptional regulation of adipocytes differ-
entiation and proliferation. Namely, it has been recognized that
this molecule increases the expression and/or the binding activity
of PPARγ [161] and C/EBPβ [152].
MnSOD, catalase, peroxiredoxins, thioredoxin reductase (TR),
and glutathione peroxidase play important roles in the prevention
of the excessive level of O2 and H2O2 during adipocytes differ-
entiation [153,163–165]. Actually, the expression of selenoproteins
P and S and GPx (GPx 1, GPx 3 and GPx 4) has been detected in the
adipose tissue, while its decreased expression or knock-down
impaired adipogenesis, and insulin signaling in the mature adi-
pocytes [156,166]. The role and regulation of thioredoxin-depen-
dent redox system in the human non-diabetic obesity seems to be
of the utmost importance, since in the obese non-diabetic humans,
a positive correlation between TR1 mRNA [167], TR activity and
thioredoxin protein level [49] and fat mass of subcutaneous adi-
pose tissue level was observed. Contrary, different anti-adipogenic
factors (TNF-α, rapamycin, an inhibitor of the mammalian target of
rapamycin – mTOR) suppressed the induction of TR1 and thior-
edoxin 2 during the course of adipogenesis [165]. Meanwhile, it
has been shown that both, the N-acetyl cysteine a glutathione
precursor and its antagonist buthionine sulfoximine, an inhibitor
of γ-glutamylcysteine synthetase and de novo GSH synthesis in-
hibit adipocyte differentiation [168,169]. Unexpectedly, inhibition
of GPx, addition of GSH and H2O2 all resulted in impaired insulin
signaling in 3T3-L1 adipocytes [166]. According to all these results,
it is conceivable that the differentiation of adipocytes is paralleled
and dependent on the shift in the redox balance, reflected by both,
the progressive increase of ROS (H2O2) and their counterbalancing
reductants. Finally, it seems that compared to less differentiated
adipocytes, mature insulin-sensitive adipocytes during the differ-
entiation process attain and operate in new, higher redox equili-
brium. That being so, increasing/decreasing of both redox sites
(oxidant and/or reductant) may disrupt the homeostatic redox
balance for the current differentiation state of adipocytes, poten-
tially restricting their adipogenic and lipogenic capacity to expand
under nutritional overload. However, increased markers of oxi-
dative stress seen in adipose tissue of insulin resistant rodents and
humans possibly result from exhausted capacity of endogenous
antioxidants to provide redox balance over the long term [49,91].
The beneficial effect of calorie restriction (CR) on insulin sen-
sitivity and metabolic health is partially mediated by its effects on
adipose tissue adipogenesis. Attenuated glucose flux trough me-
tabolic pathways in CR, increases NADþ and this is sensed trough
the NADþ-dependent class III histone deacetylases, i.e. Sirtuins
(SIRT1–SIRT7) [170]. Among them, SIRT1 directly block lipid ana-
bolism and adipogenesis by interfering with transcriptionalactivity of PPARγ in adipose tissue [43]. Importantly, SIRT1 targets
also the Forkhead-O-box (FOXO) family of transcription factors
[171,172] and PPARγ coactivator 1α (PGC-1α) [173], master reg-
ulators of lipid metabolism, stress resistance and apoptosis
[174,175], i.e. mitochondrial gene expression and mitochondrial
biogenesis [176], respectively. Deacetylation of PGC-1α and FOXOs
by SIRT1 enhances lipid catabolism and mitochondrial respiration
and reinforces mitochondrial antioxidant enzymes and uncoupling
protein 2 [177,178]. In turn, mitochondrially localized member of
sirtuin family of proteins – SIRT3, functions as a downstream
target gene of PGC-1α, mediating the PGC-1α effects on cellular
ROS production and mitochondrial biogenesis [179]. The biological
functions of SIRT3 are beginning to emerge; its overexpression
seems to increase respiration, while decreasing ROS production
[180]. Overall, SIRT1/SIRT3-mediated transcriptional reprograming
of adipogenesis/lipogenesis toward adipostasis and improved
oxidative capacity – “metabolic fitness” of adipose tissue underlie
beneficial effects of CR/CR mimetics on systemic insulin sensitivity
and metabolic homeostasis.14. Conclusion and clinical implication
In summary, the current data indicate that the function of adipose
tissue, primarily the response to insulin to accommodate energy
surplus safely, is intricately linked with the redox changes. Both the
lipogenesis and adipogenesis are controlled by the redox shift, a
mostly moderate change in the H2O2 metabolism, possibly instigated
by the mitochondrial nutrient sensing. In increased nutrient overload,
as well as during the adipogenesis both sites of the redox balance
shift to new redox equilibrium, as a part of a new metabolic home-
ostasis – to accommodate its lipid storage function. Thus, healthy
obesity is consistent with the lack of the redox stress signature, at
least in the adipose tissue. On the other side, persistent nutritional
overload, and consequent oxidative pressure, may effortlessly and
abruptly end, exceed the antioxidant capacity of the cell. In contrast to
visceral, subcutaneous adipose tissue appears to be well protected
against an increased generation of oxygen species in obese subjects
[49]. In this regard, low glutathione/thioredoxin levels are of critical
significance as the main redox buffers in the cells. If this happens,
oxidative injures begin to accumulate leading to irreversible damage
of proteins and other biomolecules, signaling pathways (insulin re-
sistance), organelles (mitochondria) and adipocytes/adipose tissue in
whole. Consistently data suggest that oxidative damage, especially at
the level of expanding visceral adipose tissue may precede adipocyte
dysfunction and the development of further metabolic disorders even
in obese, still metabolically healthy individuals [4,7,49,181–187].
Of high clinical importance, recent observations indicate that some
specific antioxidants by suppression of oxidative stress can prevent
accumulation of “bad” adipose tissue and weight gain. Celastrol, tri-
terpenoid compounds with antioxidant and anti-inflammatory
properties, was able to effectively suppress weight and alleviate high-
fat mediated cardiovascular injury via mitigating oxidative stress and
improving lipid metabolism [188]. Also, α-lipoic acid increased mi-
tochondrial content, enhanced oxygen consumption and fatty acid
oxidation enzymes in cultured white subcutaneous adipocytes from
overweight/obese donors [189]. Mitochondria from α-lipoic acid-
treated adipocytes exhibited some morphological characteristics of
brown mitochondria, and α-lipoic acid also induced up-regulation of
some brown/beige adipocytes markers. Bilobalide, a bioactive from
Gingko biloba, significantly protected adipocytes from adverse effects
of hypoxia attenuating superoxide generation, inflammation and
protecting mitochondria [190].
Actually, different agents that improve mitochondrial redox status
by reducing ROS levels and/or by increasing mitochondrial anti-
oxidant activity may be beneficial in both, reducing obesity and
A. Jankovic et al. / Redox Biology 6 (2015) 19–32 29improving the metabolic profile. A recent study demonstrated that
chronic oral melatonin improves mitochondrial respiration and re-
duces the oxidative status in inguinal white adipose tissue of Zucker
diabetic fatty rats [191]. Besides, growing evidence shows that diet-
ary supplementation with arginine, a precursor of nitric oxide, ef-
fectively reduces white adipose tissue in Zucker diabetic fatty rats,
diet-induced obese rats, and obese patients with type II diabetes
[143,192,193]. L-Arginine upregulates lipolysis and fatty acid oxida-
tion, and inhibits fatty acid synthesis an adipose tissue. The under-
lying mechanisms involve increases in the expression of PGC-1α,
mitochondrial biogenesis, the growth of brown adipose tissue. More
importantly, oxidative stress in white adipose tissue of high fat-fed
rats was prevented by L-arginine supplementation probably by in-
ducing endogenous antioxidant enzymes [143]. Accordingly, L-argi-
nine holds promise as a safe nutrient to reduce adiposity and im-
prove the metabolic profile in animals and humans.
It appears that the modulation of redox metabolism in adipose
tissue by different redox active molecules may provide a promis-
ing strategy for the prevention/treatment of insulin resistance and
metabolic syndrome. On the other hand, due to the complex ROS
function in adipocytes and different redox tone in adipose tissue
from different body sites, it is not surprising that conventional AD
therapies with vitamins even show a negative effect on systemic
insulin sensitivity [194,195]. The explanation would be that any
intervention from this direction (by continuous exogenous anti-
oxidant supplementation) interrupts the adipose tissue depot-
specific dynamic steady state balance.
Overall, antioxidant supplements cannot compensate for a
Western diet and sedentary lifestyle, but antioxidant-rich foods
and/or supplements that reinforce endogenous antioxidant de-
fense in parallel with promoting of browning of adipose tissue can
improve the organ damage and late complications of obesity and
hyperglycemia [140,196].Acknowledgements
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